findmyKOL
Clinical trialNCT00352677CompletedPhase 1Interventional

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

SponsorCytRxEnrollment100Acute Lymphocytic LeukemiaChronic Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Charite University of Medicine

    Berlin, Germany

  • Johann Wolfgang Goethe Universität

    Frankfurt am Main, Germany

  • University of Heidelberg Medical Clinic

    Mannheim, Germany

Israel
  • Chaim Sheba Medical Center

    Tel Litwinsky, Israel

United States
  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, United States

  • University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bafetinib
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2006
Primary completion
31 May 2008
Completion
31 May 2008
Last update posted
1 Jun 2009
Registered enrollment
100
Registry id
NCT00352677

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.